المؤلفون: André Burckel, Kathleen Terpend, Benoît Foligné, Bruno Pot, Sophie Drouault-Holowacz, Denise Goudercourt, Véronique Dennin

المساهمون: Industrial Microbiology, Department of Bio-engineering Sciences

مصطلحات موضوعية: Leukocytes, Mononuclear/metabolism, mice, medicine.drug_class, Anti-Inflammatory Agents, Bifidobacterium/growth & development, Critical Care and Intensive Care Medicine, Inflammatory bowel disease, Peripheral blood mononuclear cell, Anti-Inflammatory Agents/therapeutic use, Severity of Illness Index, Anti-inflammatory, law.invention, dietary supplements, Probiotic, Cytokines/biosynthesis, Random Allocation, law, In vivo, medicine, Animals, Humans, Colitis, Cells, Cultured, Bifidobacterium, Colitis/chemically induced, Mice, Inbred BALB C, Nutrition and Dietetics, biology, business.industry, Inflammatory Bowel Diseases, medicine.disease, biology.organism_classification, Ulcerative colitis, Lactobacillus, Disease Models, Animal, Trinitrobenzenesulfonic Acid/toxicity, Treatment Outcome, Trinitrobenzenesulfonic Acid, probiotics, Immunology, Leukocytes, Mononuclear, Cytokines, Female, Lactobacillus/growth & development, business, Inflammatory Bowel Diseases/microbiology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de779d3fca94d16c32268460b7bdb417
https://hdl.handle.net/20.500.14017/6d3b27b8-9791-4100-a232-efbd3b34f512